Fifth Third Bancorp Novavax Inc Transaction History

Fifth Third Bancorp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$121.0 - $257.67 $3,025 - $6,441	-25 Reduced 2.42%	1,010 $214,000
Q1 2021 May 07, 2021	SELL	$112.98 - $319.93 $44,062 - $124,772	-390 Reduced 27.37%	1,035 $188,000
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $12,992 - $23,017	-165 Reduced 10.38%	1,425 $159,000
Q3 2020 Nov 09, 2020	BUY	$79.44 - $178.51 $42,103 - $94,610	530 Added 50.0%	1,590 $172,000
Q2 2020 Aug 05, 2020	BUY	$13.86 - $83.61 $693 - $4,180	50 Added 4.95%	1,060 $88,000
Q1 2020 May 05, 2020	BUY	$3.93 - $16.0 $3,969 - $16,160	1,010 New	1,010 $14,000
Q4 2019 Feb 14, 2020	SELL	$3.69 - $5.22 $369 - $522	-100 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $401 - $784	100 New	100 $1,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.